Lupin bags tentative USFDA okay for generic HIV Medication Ruchika Sharma4 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
USFDA completes inspection of Lupin Somerset facility with no observations Ruchika Sharma3 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval...
USFDA nod to Lupin Ipratropium Bromide Nasal Solution for runny nose Ruchika Sharma29 Jan 2025 3:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Avas unveil myotonia treatment NaMuscla in Italy Ruchika Sharma29 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug NaMuscla (mexiletine) in...
Lupin receives USFDA approval for heart failure drug Ruchika Sharma24 Jan 2025 4:24 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration...
Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin unveils pregnancy prevention drug Minzoya in US Ruchika Sharma14 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous...
Lupin Cystic fibrosis drug gets tentative approval from USFDA Ruchika Sharma10 Jan 2025 2:30 PM ISTIvacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis treatment in patients aged 4 months and older.
Lupin bags tentative USFDA nod for Loteprednol Etabonate Ophthalmic Gel Ruchika Sharma10 Jan 2025 11:35 AM ISTLoteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular...
Lupin Pithampur Unit-1 facility gets EIR from USFDA Ruchika Sharma9 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Diabetes treatment: Lupin buys Huminsulin from Eli Lilly Ruchika Sharma31 Dec 2024 12:52 PM ISTMumbai: Global pharma major Lupin Limited has announced the acquisition of Huminsulin in India from Eli Lilly and Company to further enhance its...
USFDA approves Lupin drug for HIV-1 infection Ruchika Sharma18 Dec 2024 5:11 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
